Evidence map›Paper›PMID 24465678›Full record

ArticlePloS one2014

Multiple modes of impulsivity in Parkinson's disease.

Cristina Nombela, Timothy Rittman, Trevor W Robbins, James B Rowe

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 134 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Impulse Control Disorders Are Independent of Parkinson Disease Motor Subtypes.medRxiv : the preprint server for health sciences · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  16. Review
  17. Quality of life implications for elevated trait impulsivity in people with Parkinson's disease.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Observational
  18. Article
  19. Article
  20. Impulsivity traits and awareness of motor intention in Parkinson's disease: a proof-of-concept study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Cristina NombelaDepartment of Clinical Neurosciences, Cambridge University, Cambridge, United Kingdom.
Timothy RittmanDepartment of Clinical Neurosciences, Cambridge University, Cambridge, United Kingdom.
Trevor W RobbinsDepartment of Psychology, Cambridge University, Cambridge, United Kingdom ; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom.
James B RoweDepartment of Clinical Neurosciences, Cambridge University, Cambridge, United Kingdom ; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom ; Medical Research Council, Cognition and Brain Sciences Unit, Cambridge, United Kingdom.
University of Cambridge · GBMRC Cognition and Brain Sciences Unit · GB

Funding

Medical Research Council G0001354Medical Research Council G1100464Medical Research Council MC-A060-5PQ30Medical Research Council MC_U105597119Wellcome TrustWellcome Trust 088324
6 · The paper itself

Abstract

Cognitive problems are a major factor determining quality of life of patients with Parkinson's disease. These include deficits in inhibitory control, ranging from subclinical alterations in decision-making to severe impulse control disorders. Based on preclinical studies, we proposed that Parkinson's disease does not cause a unified disorder of inhibitory control, but rather a set of impulsivity factors with distinct psychological profiles, anatomy and pharmacology. We assessed a broad set of measures of the cognitive, behavioural and temperamental/trait aspects of impulsivity. Sixty adults, including 30 idiopathic Parkinson's disease patients (Hoehn and Yahr stage I-III) and 30 healthy controls, completed a neuropsychological battery, objective behavioural measures and self-report questionnaires. Univariate analyses of variance confirmed group differences in nine out of eleven metrics. We then used factor analysis (principal components method) to identify the structure of impulsivity in Parkinson's disease. Four principal factors were identified, consistent with four different mechanisms of impulsivity, explaining 60% of variance. The factors were related to (1) tests of response conflict, interference and self assessment of impulsive behaviours on the Barrett Impulsivity Scale, (2) tests of motor inhibitory control, and the self-report behavioural approach system, (3) time estimation and delay aversion, and (4) reflection in hypothetical scenarios including temporal discounting. The different test profiles of these four factors were consistent with human and comparative studies of the pharmacology and functional anatomy of impulsivity. Relationships between each factor and clinical and demographic features were examined by regression against factor loadings. Levodopa dose equivalent was associated only with factors (2) and (3). The results confirm that impulsivity is common in Parkinson's disease, even in the absence of impulse control disorders, and that it is not a unitary phenomenon. A better understanding of the structure of impulsivity in Parkinson's disease will support more evidence-based and effective strategies to treat impulsivity.

Indexed as

AdultAgedCase-Control StudiesDemographyFemaleHumansImpulsive BehaviorLinear ModelsMaleMiddle AgedModels, NeurologicalNeurotransmitter AgentsParkinson DiseasePrincipal Component AnalysisTask Performance and AnalysisNeurotransmitter Agents

Identifiers

PMID24465678
PMCPMC3897514
OpenAlexW1999273199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.